Severe Acute Respiratory Syndrome Therapeutics Market - Global Outlook and Forecast 2021-2027

Code: RW00014560604
Market Monitor Global
Oct-2021
Life Sciences
91 Pages

This report contains market size and forecasts of Severe Acute Respiratory Syndrome (SARS) Therapeutics in Global, including the following market information:
Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Severe Acute Respiratory Syndrome (SARS) Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Severe Acute Respiratory Syndrome (SARS) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Segment Percentages, By Type, 2020 (%)
CEL-1000
D-3252
FDX-000
INO-4500
LCA-60
Others

China Severe Acute Respiratory Syndrome (SARS) Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Research Center

Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
CEL-SCI Corporation
GeneCure LLC
Humabs BioMed SA
Inovio Pharmaceuticals, Inc.
Nanotherapeutics, Inc.
Novavax, Inc.
Phelix Therapeutics, LLC
Protein Sciences Corporation

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Overall Market Size
2.1 Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size: 2021 VS 2027
2.2 Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Severe Acute Respiratory Syndrome (SARS) Therapeutics Players in Global Market
3.2 Top Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Companies Ranked by Revenue
3.3 Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Severe Acute Respiratory Syndrome (SARS) Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Severe Acute Respiratory Syndrome (SARS) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Severe Acute Respiratory Syndrome (SARS) Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Severe Acute Respiratory Syndrome (SARS) Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Severe Acute Respiratory Syndrome (SARS) Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size Markets, 2021 & 2027
4.1.2 CEL-1000
4.1.3 D-3252
4.1.4 FDX-000
4.1.5 INO-4500
4.1.6 LCA-60
4.1.7 Others
4.2 By Type - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Center
5.2 By Application - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue, 2016-2027
6.3.2 US Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.3.3 Canada Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.3.4 Mexico Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue, 2016-2027
6.4.2 Germany Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.4.3 France Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.4.4 U.K. Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.4.5 Italy Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.4.6 Russia Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.4.8 Benelux Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue, 2016-2027
6.5.2 China Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.5.3 Japan Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.5.4 South Korea Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.5.6 India Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue, 2016-2027
6.6.2 Brazil Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.6.3 Argentina Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue, 2016-2027
6.7.2 Turkey Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.7.3 Israel Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
6.7.5 UAE Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 CEL-SCI Corporation
7.1.1 CEL-SCI Corporation Corporate Summary
7.1.2 CEL-SCI Corporation Business Overview
7.1.3 CEL-SCI Corporation Severe Acute Respiratory Syndrome (SARS) Therapeutics Major Product Offerings
7.1.4 CEL-SCI Corporation Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue in Global (2016-2021)
7.1.5 CEL-SCI Corporation Key News
7.2 GeneCure LLC
7.2.1 GeneCure LLC Corporate Summary
7.2.2 GeneCure LLC Business Overview
7.2.3 GeneCure LLC Severe Acute Respiratory Syndrome (SARS) Therapeutics Major Product Offerings
7.2.4 GeneCure LLC Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue in Global (2016-2021)
7.2.5 GeneCure LLC Key News
7.3 Humabs BioMed SA
7.3.1 Humabs BioMed SA Corporate Summary
7.3.2 Humabs BioMed SA Business Overview
7.3.3 Humabs BioMed SA Severe Acute Respiratory Syndrome (SARS) Therapeutics Major Product Offerings
7.3.4 Humabs BioMed SA Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue in Global (2016-2021)
7.3.5 Humabs BioMed SA Key News
7.4 Inovio Pharmaceuticals, Inc.
7.4.1 Inovio Pharmaceuticals, Inc. Corporate Summary
7.4.2 Inovio Pharmaceuticals, Inc. Business Overview
7.4.3 Inovio Pharmaceuticals, Inc. Severe Acute Respiratory Syndrome (SARS) Therapeutics Major Product Offerings
7.4.4 Inovio Pharmaceuticals, Inc. Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue in Global (2016-2021)
7.4.5 Inovio Pharmaceuticals, Inc. Key News
7.5 Nanotherapeutics, Inc.
7.5.1 Nanotherapeutics, Inc. Corporate Summary
7.5.2 Nanotherapeutics, Inc. Business Overview
7.5.3 Nanotherapeutics, Inc. Severe Acute Respiratory Syndrome (SARS) Therapeutics Major Product Offerings
7.5.4 Nanotherapeutics, Inc. Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue in Global (2016-2021)
7.5.5 Nanotherapeutics, Inc. Key News
7.6 Novavax, Inc.
7.6.1 Novavax, Inc. Corporate Summary
7.6.2 Novavax, Inc. Business Overview
7.6.3 Novavax, Inc. Severe Acute Respiratory Syndrome (SARS) Therapeutics Major Product Offerings
7.6.4 Novavax, Inc. Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue in Global (2016-2021)
7.6.5 Novavax, Inc. Key News
7.7 Phelix Therapeutics, LLC
7.7.1 Phelix Therapeutics, LLC Corporate Summary
7.7.2 Phelix Therapeutics, LLC Business Overview
7.7.3 Phelix Therapeutics, LLC Severe Acute Respiratory Syndrome (SARS) Therapeutics Major Product Offerings
7.4.4 Phelix Therapeutics, LLC Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue in Global (2016-2021)
7.7.5 Phelix Therapeutics, LLC Key News
7.8 Protein Sciences Corporation
7.8.1 Protein Sciences Corporation Corporate Summary
7.8.2 Protein Sciences Corporation Business Overview
7.8.3 Protein Sciences Corporation Severe Acute Respiratory Syndrome (SARS) Therapeutics Major Product Offerings
7.8.4 Protein Sciences Corporation Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue in Global (2016-2021)
7.8.5 Protein Sciences Corporation Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Opportunities & Trends in Global Market
Table 2. Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Drivers in Global Market
Table 3. Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Restraints in Global Market
Table 4. Key Players of Severe Acute Respiratory Syndrome (SARS) Therapeutics in Global Market
Table 5. Top Severe Acute Respiratory Syndrome (SARS) Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Severe Acute Respiratory Syndrome (SARS) Therapeutics Product Type
Table 9. List of Global Tier 1 Severe Acute Respiratory Syndrome (SARS) Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Severe Acute Respiratory Syndrome (SARS) Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

CEL-SCI Corporation
GeneCure LLC
Humabs BioMed SA
Inovio Pharmaceuticals, Inc.
Nanotherapeutics, Inc.
Novavax, Inc.
Phelix Therapeutics, LLC
Protein Sciences Corporation

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE